Results 141 to 150 of about 14,177 (223)

DYT-40, a novel synthetic 2-styryl-5-nitroimidazole derivative, blocks malignant glioblastoma growth and invasion by inhibiting AEG-1 and NF-κB signaling pathways. [PDF]

Sci Rep, 2016
Zou M, Duan Y, Wang P, Gao R, Chen X, Ou Y, Liang M, Wang Z, Yuan Y, Wang L, Zhu H.   +10 more
europepmc   +1 more source

Prevalence of Nitroimidazole-Refractory Giardiasis Acquired in Different World Regions, Sweden, 2008-2020. [PDF]

Emerg Infect Dis
Ydsten KA, Öhd JN, Hellgren U, Asgeirsson H.   +3 more
europepmc   +1 more source

In Vitro Antifungal Activity of Thiosemicarbazide Derivatives with a Nitroimidazole Moiety Against <i>Trichophyton</i> spp. Dermatophytes. [PDF]

Molecules
Andrzejczuk S, Kosikowska U, Wujec M.
europepmc   +1 more source

Expanded therapeutic potential in activity space of next-generation 5-nitroimidazole antimicrobials with broad structural diversity. [PDF]

Proc Natl Acad Sci U S A, 2013
Miyamoto Y, Kalisiak J, Korthals K, Lauwaet T, Cheung DY, Lozano R, Cobo ER, Upcroft P, Upcroft JA, Berg DE, Gillin FD, Fokin VV, Sharpless KB, Eckmann L.   +13 more
europepmc   +1 more source

Photocatalytic degradation of Metronidazole with illuminated TiO nanoparticles [PDF]

core   +1 more source

Strategies for Pancreatic Cancer-Responsive Nanodrug Platforms Targeting Tumor Hypoxic Environments. [PDF]

Int J Nanomedicine
Joo KS, Sym SJ, Kim KM, Khang D.
europepmc   +1 more source

Indolequinone-Based Hypoxia-Activated Proteolysis Targeting Chimeras Selectively Degrade BRD4 in Hypoxic Cancer Cells. [PDF]

J Am Chem Soc
Serafini M, Twigger SA, Delfas G, Mallerman M, Bailey EP, Calder EDD, Hammond EM, Conway SJ.   +7 more
europepmc   +1 more source

Azomycin produced by <i>Pseudomonas</i> has both phytotoxic and anti-oomycete activity. [PDF]

J Bacteriol
Morales Moreira ZP, Kak K, Wei Z-W, Yanez-Ortuno D, Wang NR, Hedges JB, Chen MY, Geissmann Q, Zhang W, Chatterton S, Ryan KS, Haney CH.   +11 more
europepmc   +1 more source

<i>In vitro</i> exposure to clofazimine can select for delamanid and pretomanid resistance in <i>Mycobacterium tuberculosis</i>. [PDF]

Antimicrob Agents Chemother
Rupasinghe P, Ismail N, Mulders W, Warren RM, Joseph L, Ngcamu D, Gwala T, Omar SV, Vereecken J, de Jong BC, Rigouts L, Borroni E, Cirillo DM, Schön T, Miotto P, Köser CU.   +15 more
europepmc   +1 more source